San Antonio—The first randomized controlled trial testing a scalp-cooling device has demonstrated that it can prevent hair loss in patients undergoing chemotherapy. Although various scalp-cooling devices have been used in Europe for years, and in the United States since 2015, the SCALP (Scalp Cooling Alopecia Prevention) trial is the first to rigorously test such a device.
“The results of our interim analysis showed that in the scalp-cooling group, 50% of participants retained their